TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, and Afaxys Pharma, LLC, a pharmaceutical company focused on serving women in the public health system, announced today that they have entered into an agreement to expand access to ANNOVERA® (segesterone acetate and ethinyl estradiol vaginal system) in the United States public health sector.
February 13, 2020
· 9 min read